Safety and Utilization of Blood Components as Therapeutic Delivery Systems
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
275-282
Author(s):
Tiffany Adams, Fars Alanazi and D. Robert Lu
Attenuating Muscle Wasting: Cell and Gene Therapy Approaches
Journal:
Current Genomics
Volume:
4
Page:
575-585
Author(s):
A. Musaro and N. Rosenthal
Modified Envelope Glycoproteins to Retarget Retroviral Vectors
Journal:
Current Gene Therapy
Volume:
3
Page:
405-410
Author(s):
Catherine Haynes, Otto Erlwein and Barbara S. Schnierle
Integrated, Molecular Engineering Approaches to Develop Prostate Cancer Gene Therapy
Journal:
Current Gene Therapy
Volume:
3
Page:
452-467
Author(s):
Lily Wu and Makoto Sato
Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2009-2023
Author(s):
Elke S. Bergmann-Leitner, Elizabeth H. Duncan and Wolfgang W. Leitner
Porphyrins as Radiosensitizing Agents for Solid Neoplasms
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2024-2035
Author(s):
M. Schaffer, B. Ertl-Wagner, P. M. Schaffer, U. Kulka, A. Hofstetter, E. Duhmke and G. Jori
Src Family Kinases: Potential Targets for the Treatment of Human Cancer and Leukemia
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2043-2059
Author(s):
Markus Warmuth, Robert Damoiseaux, Yi Liu, Doriano Fabbro and Nathanael Gray
Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2067-2077
Author(s):
J. Brtko and J. Thalhamer
Recent Developments in the Field of Tumor-Inhibiting Metal Complexes
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2078-2089
Author(s):
M. S. Galanski, V. B. Arion, M. A. Jakupec and B. K. Keppler
CB 1954: From the Walker Tumor to NQO2 and VDEPT
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2091-2104
Author(s):
Richard J. Knox, Philip J. Burke, Shiuan Chen and David J. Kerr